腎細胞癌の治療成績

阿曽 佳郎; 増田 宏昭; 広瀬 淳; 麦谷 荘一; 丸山 正明; 三橋 孝; 山口 安三; 中野 優; 塚田 隆; 鈴木 明彦; 中原 正男; 北川 元昭; 鈴木 俊秀; 神林 知幸; 牛山 知己; 畑 昌宏; 太田 信隆; 大見 嘉郎; 大田原 佳久; 鈴木 和雄; 田島 惇

doi:10.5980/jpnjurol1928.79.6_1096

THE RESULTS OF TREATMENT FOR RENAL CELL CARCINOMA

Yoshio Aso, Hiroaki Masuda, Jun Hirose, Souichi Mugiya, Masaaki Maruyama, Takashi Mitsuhashi, Yasuzou Yamaguchi, Masaru Nakano, Takashi Tsukada, Akihiko Suzuki, Masao Nakahara, Motoaki Kitagawa, Toshihide Suzuki, Tomoyuki Kanbayashi, Tomomi Ushiyama, Masahiro Hata, Nobutaka Ohta, Yoshirou Ohmi, Yoshihisa Ohtawara, Kazuo Suzuki, Atushi Tajima

Author information

Yoshio Aso
Department of Urology, Faculty of Medicine, The University of Tokyo
Hiroaki Masuda
Department of Urology, Hamamatsu University School of Medicine
Jun Hirose
Department of Urology, Hamamatsu University School of Medicine
Souichi Mugiya
Department of Urology, Hamamatsu University School of Medicine
Masaaki Maruyama
Department of Urology, Hamamatsu University School of Medicine
Takashi Mitsuhashi
Department of Urology, Hamamatsu University School of Medicine
Yasuzou Yamaguchi
Department of Urology, Hamamatsu University School of Medicine
Masaru Nakano
Department of Urology, Hamamatsu University School of Medicine
Takashi Tsukada
Department of Urology, Hamamatsu University School of Medicine
Akihiko Suzuki
Department of Urology, Hamamatsu University School of Medicine
Masao Nakahara
Department of Urology, Hamamatsu University School of Medicine
Motoaki Kitagawa
Department of Urology, Hamamatsu University School of Medicine
Toshihide Suzuki
Department of Urology, Hamamatsu University School of Medicine
Tomoyuki Kanbayashi
Department of Urology, Hamamatsu University School of Medicine
Tomomi Ushiyama
Department of Urology, Hamamatsu University School of Medicine
Masahiro Hata
Department of Urology, Hamamatsu University School of Medicine
Nobutaka Ohta
Department of Urology, Hamamatsu University School of Medicine
Yoshirou Ohmi
Department of Urology, Hamamatsu University School of Medicine
Yoshihisa Ohtawara
Department of Urology, Hamamatsu University School of Medicine
Kazuo Suzuki
Department of Urology, Hamamatsu University School of Medicine
Atushi Tajima
Department of Urology, Hamamatsu University School of Medicine

JOURNAL FREE ACCESS

1988 Volume 79 Issue 6 Pages 1096-1102

DOI https://doi.org/10.5980/jpnjurol1928.79.6_1096

Details

Abstract

The present study reports the results of treatment in 67 cases of renal cell carcinoma during the 10 years from 1977 to 1987. Overall 1, 3 and 5-year survival rates by Kaplan-Meier method were 79.8, 64.1 and 55.5 percents, respectively.
Several factors which might be related to prognosis were analysed. As a result, anemia, increased erythrocyte sedimentation rate, postive C-reactive protein, decreased serum albumin, elevated serum α₁-globlin and mixed echo pattern were found to be poor prognostic factors. By pathological study, the stage and the histological grade of tumors were found to be significant prognostic factors, while the importance of cell type, structual pattern and microinfiltration as a prognostic factor was not clearly demonstrated.
The cases with renal cell carcinoma were treated with the combined adjuvant therapy of chemotherapy (FT 207, 5-FU or UFT) and nonspecific immunotherapy (OK-432: Picibanil) postoperatively. It appeared that the postoperative adjuvant therapy was useful for the improvement of prognosis.

Corresponding author

Register with J-STAGE for free!